Misc Games is a game developer based in Stavanger – Norway, with several collaborators around the world. We make games for PC/Consoles. Misc Games aims at developing unique games for various niche markets. We treat developers like human beings and video games like art rather than toys. Everyone at Misc Games has a strong passionate for video games and that’s why we want to evolve the industry into something better. We want to develop games mostly for the more mature and educated gamers.

We develop business with positive impact on the environment and society – creating more with less based on game changing new technologies. Our ambition is to create synergies of resources available, from the Earth, from research and between people and networks. Therefore, we have chosen Vili Vé as our name, from the two brothers of Odin who created fjords and mountains out of the resources available from Ymir. Our focus areas are cleantech and life science, our primary market is Europe and Asia, our customers and partners are major manufacturers, distributors, B2B customers and consulting companies. Our team, communication and style reflects diversity and openness, and our teamwork is based on dedication and trust. We want our customers and partners to experience us as competent, genuine and attentive – and proactively focusing on win-win solutions.

Manolin is a software company focusing on digital health management to accelerate resource sharing between salmon farms. We are a software and data analytics company helping global aquaculture scale sustainably. 🌊 Our ocean faces many challenges, but it holds even more potential for positive impact. Our goal is to help build a more sustainable future food system together with aquaculture farmers.

Estro has developed a patented solution to improve Fish Health for Norwegian and International Fish farms, the "SeaNest" solution reduce mortality, and facilitate and improve the working environment for both farmer and Fish. A controllable solution for the clean Fish in the Battle against the lice, zero contamination, and no loose parts eliminate the risk of pollution. Easy to Wash and handle. We have signed a full-scale test program with some of the largest companies within the business, and so far with a positive result. First Emission fulfilled mid of 2018, and the commercialization process started.

We are in the process of the first production through a Norwegian partner. What we are interested in is getting in touch with companies that can help us to further develop a product that will be something you buy in addition to our Bag'in. This product is currently working on patenting as it is so unique. The prototype is designed by Kåre.

Secure Payment Transaction System with #1 Ranking Our App is integrated with the most secure payment gateways in the world. We use the most advanced encryption technology to ensure that your payment is safe and secure. We are the first to integrate local banks directly with < 1% transaction fee thanks to PSD2 License ( Card-Less Transactional Handshake )

On a mission to help professional writers use clearer language In 2014, we started our journey to create a world-class writing assistant based on deep learning. Freelancers, Journalists, marketing, public servants, and others can lift their relevance, target precision, and message clarity using Upfeed’s AI-driven writing assistant.

Move is an IT infrastructure consulting company and system integrator covering the areas of Network and Security, Virtualization, Database and OS platforms, and high-end server/storage. Move delivers: High expertise advisor and consultancy services Design and implementation of complex projects Diversified service and support services Project Management IT-solutions

UpStacked is the All-in-One centralized operations platform that crushes SLA requirements to increase profitability and reduce OPEX. Purpose-built for internal IT and MSPs to operate SMBs and Enterprises. With user experience in mind, UpStacked drives complex to zero-touch, through automation and machine learning. UpStacked at a Glance: - All-in-One Centralized Platform - Enterprise onboarding in minutes - Third-Party integrations - Zero-Touch - Simplified License Management - Real-Time On-Demand Reporting - Real-Time Topology Based Correlation - Real-Time Event-Based Correlation - Built-in Role Based Access Control - Natively Multi-Tenant - Multi-Vendor - ITIL

Movel AS provides support and invoicing services for AC charging systems. We specialize in systems that provide normal charging for long-term and overnight parking. Movel wants to contribute to a more environmentally friendly life. Therefore, all power in Movel's charging systems provides renewable energy.

Bile duct cancer is an aggressive form of cancer with an extremely poor overall five-year survival rate of just 2-5 %. Classified as an orphan disease, annual incidence in Europe and the United States of 15-22,000 patients, and a significantly higher incidence in Asia, makes it a major player and the deadliest of the gastrointestinal cancers. Only a small number of patients are eligible for a complete surgical resection by local resection or liver transplantation, and more than 50% of these relapse. The vast majority are treated by gemcitabine-based palliative chemotherapy with a life expectancy of 11 months, and five-year survival rate of zero %. Thus, there is an urgent and unmet medical need to develop new and better treatment strategies for these patients. The innovations developed by Seald are a result of adopting a multidisciplinary approach to the diagnosis and treatment of bile duct cancer, based on extensive drug sensitivity assays on living cancer cells, molecular biomarkers, DNA sequencing, extensive bioinformatics analyses and zebrafish models. Sealds’s holistic approach is unique with possible modes of action that can be used on other solid cancers. Our technology includes drug repurposing and innovation on new medical substances, diagnostics and methodology. The stipulated pharma market globally is USD 2.1-4.2 billion, in addition to the markets for diagnostics and platform technology

Biozep is discovering and developing first-in-class drug products for the treatment of severe eye diseases which can lead to vision loss and where it is a high unmet medical need. Biozep has discovered novel drug substances based on bioactive lipids which modulate central pathways involved in the pathogenesis of eye diseases. Targets and biomarkers are identified based on a system biology approach combined with in-depth knowledge about bioactive lipids, their endogenous synthesis and mechanisms of action. Biozep has made a prototype drug product based on our lead compound for topical administration and the product will be tested in animal models in 2018. Our goal is to start clinical studies in 2020. Biozep is a company depending on both internal and external resources. Biozep has established its own laboratory in Oslo in order to do synthesis, purification, quality control and chemical development in-house. The biological testing of the drug substances is performed in collaboration with carefully selected contract research organizations both in Europe and the USA. In order to reach the market as fast as possible and to reduce risk, Biozep will seek strategic partnerships early in the drug development phase. Biozep seeks partners with complementary competence and with resources to conduct clinical trials and with market access. We are already in dialogue with potential partners and hope to sign an agreement in 2018-19.

We start our project in 2017. We develop and offer to the market ecological & sustainable fertilizers made by mineral and organic nature. We cultivate a unique product and engage experience and innovation. By offering a quality product with added value to our customers, we help make a cost-effective solution for horticulture and agriculture.  We are happy to be engaged in the optimization of performance for allied businesses and private customers.

Together with four Norwegian hospitals, we have developed the next generation hospital bed. A bed that prevents pressure ulcers, fall and reduce nurse load by removing heavy lifting and monitors the patients state, non intrusive. Have recieved contracts in Toronto that accelerates development, and secures uptake and sales if the clinical trial goes as planned.

Willy Roger Jacobsen startet Norwegian Food Partner AS i 2012. Han har arbeidet med salg og markedsføring i næringsmiddelindustrien siden 1974. Han har hatt stillinger i Rieber og Søn, Toro, Denja og Minde Sjokolade. Fra 2000 til 2012 har han bygget opp og ledet Brynhildsen AS til en betydelig aktør i norsk dagligvare med mange ledende merkevarer. I 2012 overtok han eierskapet i Vossakjøt AS og har ledet en snuoperasjon som har gitt bedriften en solid omsetningsøkning. Han blant annet har lagt vekt på markedsføring og riktig distribusjon for å få dette til. Norwegian Food Partner AS har også andre interessante samarbeidspartnere. Catrine Nordvik er økonomi og administrasjonssjef i Norwegian Food Partner.